Benchmark Holdings increased its turnover by 33 percent to £79.2 million in the first half of the financial year 2022 which ended on 31 March this year. In the same period, operating profit (adjusted EBITDA) increased by 100 percent to £15.9 million, compared with the same period in the previous financial year.
“The numbers speak for themselves. We are now reaping the benefits of the significant efforts that have been made in the last couple of years through the restructuring of the business, renewed and strengthened commercial focus and financial discipline. This is reflected in both growth and margin,” Trond Williksen, CEO of Benchmark Holdings, said in a statement.
Profit before tax ended at a loss of £5.1 million.
Benchmark’s activities include genetics, specialized nutrition and animal health. The group is represented in 26 countries. It offers products and solutions for species such as salmon, shrimp, sea bass and bream and tilapia.
All three business areas delivered double-digit revenue growth, doubled underlying profitability, and they show a clear increase in adjusted EBITDA in the first half of the financial year 2022 compared to the same period in 2021. The first three months of the calendar year, which is Benchmark’s second quarter, were the fourth quarter in a row with significant growth in turnover and profit.
“The year has started well. The market outlook in our most important markets for the second half of the year is good and we are well positioned to be able to deliver a good year,” Williksen says.
Benchmark Holding is listed on the London Stock Exchange. In November last year, the company engaged DNB Markets and Pareto Securities as advisors in connection with a possible listing on the Oslo Stock Exchange. Depending on market conditions, the company now aims for a listing on Euronext Growth in Oslo during the second half of 2022, with an intention to transfer to the main list on the Oslo Stock Exchange within 12 months.
